Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53

被引:0
|
作者
Lisa S St. John
Edward R Sauter
Meenhard Herlyn
Samuel Litwin
Karen Adler-Storthz
机构
[1] Dental Branch,Department of Basic Sciences
[2] Graduate School of Biomedical Sciences,Department of Biostatistics
[3] University of Texas-Houston Health Science Center,undefined
[4] The Wistar Institute,undefined
[5] Fox Chase Cancer Center,undefined
来源
Cancer Gene Therapy | 2000年 / 7卷
关键词
p53; squamous cell carcinoma; growth arrest; apoptosis; WAF1; WAF1; p21.;
D O I
暂无
中图分类号
学科分类号
摘要
Prior reports suggest that p53 protein status may influence the response to gene transduction with wild-type (wt) p53. Adenoviral vectors containing the p53 gene were administered to normal keratinocytes, to squamous cell carcinoma (SCC) lines with varied p53 protein status (absent, mutant, wt, or degraded by papillomavirus), as well as to tumors formed in severe combined immunodeficient mice. The percentage of cells undergoing apoptosis, G1 growth arrest, WAF1/p21 induction, and in vivo tumor progression were studied after wt p53 gene transduction. Apoptosis developed first in normal keratinocytes, next in SCCs lacking p53 protein, and last in SCCs with mutant or degraded p53 protein. All of the cell lines studied demonstrated an increase in WAF1/p21 protein, but only those lacking p53 protein showed G1 arrest. Tumors lacking p53 protein were more susceptible to p53 overexpression than those containing mutant or degraded p53 protein. The endogenous p53 protein status of SCCs appears to influence the outcome of p53 gene transduction.
引用
收藏
页码:749 / 756
页数:7
相关论文
共 50 条
  • [21] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Li, PX
    Bui, T
    Gray, D
    Klamut, HJ
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 48 (03) : 273 - 286
  • [22] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Peixiang Li
    Thuy Bui
    Dawn Gray
    Henry J. Klamut
    Breast Cancer Research and Treatment, 1998, 48 : 273 - 286
  • [23] Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene
    Lang, FF
    Yung, WKA
    Raju, U
    Libunao, F
    Terry, NHA
    Tofilon, PJ
    JOURNAL OF NEUROSURGERY, 1998, 89 (01) : 125 - 132
  • [24] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [25] Osteocalcin Gene Expression Is Regulated by Wild-Type p53
    Chen, Hankui
    Hays, Emily
    Liboon, Jay
    Neely, Chris
    Kolman, Kevin
    Chandar, Nalini
    CALCIFIED TISSUE INTERNATIONAL, 2011, 89 (05) : 411 - 418
  • [26] Flavonoids activate wild-type p53
    Plaumann, B
    Fritsche, M
    Rimpler, H
    Brandner, G
    Hess, RD
    ONCOGENE, 1996, 13 (08) : 1605 - 1614
  • [27] Osteocalcin Gene Expression Is Regulated by Wild-Type p53
    Hankui Chen
    Emily Hays
    Jay Liboon
    Chris Neely
    Kevin Kolman
    Nalini Chandar
    Calcified Tissue International, 2011, 89 : 411 - 418
  • [28] ACCUMULATION OF WILD-TYPE P53 IN MENINGIOMAS
    ELLISON, DW
    LUNEC, J
    GALLAGHER, PJ
    STEART, PV
    JAROS, E
    GATTER, KC
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (02) : 136 - 142
  • [29] P53 GENE-MUTATIONS IN HUMAN GASTRIC-CANCER - WILD-TYPE P53 BUT NOT MUTANT P53 SUPPRESSES GROWTH OF HUMAN GASTRIC-CANCER CELLS
    MATOZAKI, T
    SAKAMOTO, C
    SUZUKI, T
    MATSUDA, K
    UCHIDA, T
    NAKANO, O
    WADA, K
    NISHISAKI, H
    KONDA, Y
    NAGAO, M
    KASUGA, M
    CANCER RESEARCH, 1992, 52 (16) : 4335 - 4341
  • [30] Increased radiosensitivity of human glioma cells after transduction with wild-type p53, independent of cellular p53 mutation status
    Liu, Y
    Fillmore, H
    Lin, PS
    Chen, ZG
    Valerie, CK
    Broaddus, WC
    CANCER GENE THERAPY, 1999, 6 (06) : S4 - S4